Swiss National Bank - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 61 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$139,000
-42.8%
36,1000.0%0.00%
-100.0%
Q4 2014$243,000
+34.3%
36,100
+9.4%
0.00%0.0%
Q3 2014$181,000
-46.4%
33,0000.0%0.00%0.0%
Q2 2014$338,000
-14.6%
33,0000.0%0.00%
-50.0%
Q1 2014$396,000
+130.2%
33,000
+117.1%
0.00%
+100.0%
Q4 2013$172,00015,2000.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders